Prealize Health is a technology company.
Prealize Health has raised $22.0M across 1 funding round.
Prealize Health has raised $22.0M in total across 1 funding round.
Prealize Health is a Silicon Valley-based healthcare technology company that builds an AI-driven predictive analytics platform called MetisAI to transform reactive healthcare into proactive care. It serves health plans, providers, employers, specialty care management companies, and healthcare tech firms by solving key problems like inaccurate risk prediction, high costs, and inefficient resource allocation through precise forecasts of health events, financial risks, and member engagement.[1][2][4][6]
The platform delivers industry-leading accuracy (>80% in identifying rising cost and risk), enabling outcomes such as $30M in avoided medical spend for clients, 25% reduced inpatient admissions, 10% fewer ER visits, and $564 PMPM cost avoidance for engaged members. Growth momentum includes strategic partnerships like with Clarify Health (2024) for enhanced forecasting and the acquisition of CentraForce Health's Social Determinants of Health (SDoH) IP to create Comprehensive Determinants of Health™ insights.[2][4][6]
Prealize Health was founded in 2015 at Stanford University by Dr. Nigam Shah and Dr. Arnold Milstein, two industry thought leaders in clinical and care innovation. Their vision emerged from a desire to shift healthcare from reactive treatment to proactive prevention using AI and machine learning, drawing on Stanford's legacy of breakthroughs.[1][4][6]
Early traction built on assembling a team of healthcare leaders, data scientists, and engineers. The company evolved through continuous Stanford partnerships, launching a functional platform for analysts that identified rising-risk populations before issues escalated. Pivotal moments include proven results like cost savings for clients and expansions such as the CentraForce SDoH acquisition, enhancing holistic member profiles.[1][2][5][6]
Prealize stands out in healthcare analytics through these key strengths:
Prealize rides the AI-in-healthcare wave, capitalizing on trends like precision medicine and value-based care amid rising U.S. healthcare costs (projected to hit $6.8T by 2030). Timing is ideal post-COVID, with demand for predictive tools to handle utilization surges and health equity gaps.[2][4][6]
Market forces favoring it include explosive growth in healthcare AI (market to $188B by 2030) and payer/provider shifts to proactive models. Partnerships like Clarify Health amplify its reach, influencing the ecosystem by enabling precise interventions that cut costs 10-25% and improve outcomes for millions, while SDoH integration addresses social factors driving 80% of health.[4][6]
Prealize is poised for acceleration through MetisAI enhancements, deeper integrations, and expansions into personalized care via role-based UX and Comprehensive Determinants of Health™. Trends like multimodal AI, real-world evidence, and regulatory pushes for affordability will shape its path, potentially scaling to influence billions in savings.
As AI redefines healthcare precision, Prealize's Stanford roots and accuracy edge position it to lead the proactive shift—empowering organizations to not just predict, but prevent, for a healthier, more efficient future.
Prealize Health has raised $22.0M in total across 1 funding round.
Prealize Health's investors include Bonfire Ventures, Kleiner Perkins, LaunchPad, MediaLink, Anthony Saleh, Richard Branson.
Prealize Health has raised $22.0M across 1 funding round. Most recently, it raised $22.0M Series B in April 2019.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Apr 1, 2019 | $22.0M Series B | Bonfire Ventures, Kleiner Perkins, LaunchPad, MediaLink, Anthony Saleh, Richard Branson |